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Abstract
Cytosine-5 methylation within CpG dinucleotides is a potentially important mechanism of epigenetic influence on human
traits and disease. In addition to influences of age and gender, genetic control of DNA methylation levels has recently been
described. We used whole blood genomic DNA in a twin set (23 MZ twin-pairs and 23 DZ twin-pairs, N=92) as well as
healthy controls (N=96) to investigate heritability and relationship with age and gender of selected DNA methylation
profiles using readily commercially available GoldenGate bead array technology. Despite the inability to detect meaningful
methylation differences in the majority of CpG loci due to tissue type and locus selection issues, we found replicable
significant associations of DNA methylation with age and gender. We identified associations of genetically heritable single
nucleotide polymorphisms with large differences in DNA methylation levels near the polymorphism (cis effects) as well as
associations with much smaller differences in DNA methylation levels elsewhere in the human genome (trans effects). Our
results demonstrate the feasibility of array-based approaches in studies of DNA methylation and highlight the vast
differences between individual loci. The identification of CpG loci of which DNA methylation levels are under genetic control
or are related to age or gender will facilitate further studies into the role of DNA methylation and disease.
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Introduction
Epigenetic factors have recently been found to play an
important role in developmental plasticity [1–3]. The molecular
mechanisms that underlie the epigenetic modifications of pheno-
type are increasingly well understood. Coordinated changes in the
methylation of cytosine-5 at CpG dinucleotides in the promoter
regions of specific genes, changes in chromatin structure through
histone acetylation and methylation and post-transcriptional
control by microRNAs [4] have been shown to alter gene
transcription levels. Specifically, methylation of CpG-rich pro-
moter areas (CpG islands) has been identified as an important
mechanism in the dynamic regulation of gene transcription of
mammalian genes [5,6]. DNA methylation is established early in
embryogenesis [7] and is the prime mechanism of X-chromosomal
inactivation as well as of imprinting effects [8]. Differential DNA
methylation can be age-related [9,10], and is involved in a number
of disorders including human cancers [11]. As DNA methylation
plays an important role in the mechanism of epigenetic memory
[12] it is of primary interest for the study of epigenetic influences
on human traits and diseases.
Studies involving monozygotic and dizygotic twins have been
used to investigate the influence of DNA methylation on
phenotypic variation. A study using monozygotic twins discordant
for caudal duplication anomaly revealed significant differences in
DNA methylation patterns of the disease associated gene AXIN1
(NC_000016) in peripheral blood [13]. In monozygotic twins
discordant for low birth weight, differential DNA methylation was
observed in the COMT gene region (NC_000022), suggesting that
DNA methylation may provide a mechanism through which birth
weight affects the risk for schizophrenia [14]. Several studies have
since tried to find differences in DNA methylation in twins
discordant for schizophrenia with mixed results [15–18]. Analysis
of the heritability of DNA methylation in the human IGF2/H19
locus (NC_000011) in twins revealed substantial heritability and cis
genetic associations with single nucleotide polymorphisms (SNPs)
[19]. The first systematic evidence for familial clustering of DNA
methylation presented longitudinal DNA methylation changes as
well as genetic influences [20]. Further evidence that DNA
methylation patterns are heritable came from a recent twin study
using white blood cells and buccal tissue although this study
suggested that the molecular mechanisms of heritability may not
be restricted to DNA sequence differences [21].
Based on these recent findings a picture is emerging in which
DNA methylation levels at specific loci are to some degree under
genetic control [19,21–23] and subject to changes over time.
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6767Previous studies observed that patterns of epigenetic modification
diverge in twins as they become older and suggest that this could
be due to small defects in transmitting epigenetic information
through successive cell divisions, or maintaining it in differentiated
cells [24,25]. This process, termed ‘‘epigenetic drift’’, is associated
with the aging process. In addition to the reported associations of
DNA methylation levels with age and genotype, there is evidence
that methylation levels are related to gender. There are several
studies that found higher global DNA methylation levels in males
[22]. Studies on gender-associated differences in DNA methylation
at specific loci have yielded contrasting results [26].
To investigate the heritability of DNA methylation as well as the
effects of age and gender, we performed a pilot study of DNA
methylation in healthy twin and control subjects using the Illumina
GoldenGate Methylation assay. In this assay 1,505 CpG sites from
more than 800 genes in the human genome are interrogated
simultaneously. The aim of the study was two-fold. First, we were
interested to see whether it was feasible to successfully measure
DNA methylation levels in blood using commercially available
arrays. Second, we determined whether previously reported effects
of age, gender and genotype on DNA methylation levels were
restricted to specific loci and whether the effects sizes were large
enough to be detected.
Results
DNA Methylation analysis
We generated DNA methylation data of MZ twins (N=43), DZ
twins (N=43) and 96 healthy singletons using peripheral blood
DNA samples and the GoldenGate Methylation assay. First, we
used BeadStudio software to obtain intensity measures (the mean
cy3+cy5 value) for each sample. Using a threshold intensity value
of 4,000, we eliminated eight subjects from five pairs (including
replicate pairs) in the twin set from further analysis. We next
excluded eight probes that had a detection p-value.0.05 in more
than 5 % of the hybridizations. The failure rate in the remaining
1,497 probes was ,0.01 %. We repeated the above steps for the
96 healthy control subjects included in the second set. In the latter
series, 11 of the 1,505 DNA methylation probes and one subject
failed quality control and were removed from further analysis.
We performed two-dimensional unsupervised hierarchical
clustering of autosomal loci in the filtered data set (Heatmap
and histogram shown in Supplementary Figures S1 and S2). These
analyses showed a bimodal distribution of DNA methylation [27].
A large proportion of the probes showed no or very little variation
in DNA methylation levels and were either fully methylated or
unmethylated. Since Illumina arrays can only reliably estimate
DNA methylation differences greater or equal to 17 percent only
probes with a sufficient range were included for further analysis
(See methods). From the 411 probes with normal distribution in
both sets as well as in the combined set, 131 failed the range
criterion leaving 280 high quality probes in 250 genes for further
study of heritability, age and gender effects.
Age-related DNA methylation
We investigated the association between DNA methylation
levels of the 280 high-quality probes with age. We observed a
strong correlation between the two experiments with an overall
Spearman correlation for t-values of 0.77 (95% CI: 0.71–0.81).
The combined analyses identified a total of 58 probes that were
significantly related to age (21.5 percent). Six loci also showed a
significant correlation with age in both samples series indepen-
dently (Table 1). The genes represented by these probes were
activin A receptor type I (ACVR1) (NM_001105.2), interleukin 6
(IL6) (NM_000600.1), caspase recruitment domain-containing
protein 15 (CARD15) (NM_022162.1), platelet-derived growth
Table 1. DNA methylation probes with significant effects of age and gender (listed are genes for which significance was detected
in both series independently).
Range Twins Singletons
Probe min max B.x Chi2.x p.x p.fdr.x B.y Chi2.y p.y p.fdr.y Symbol GenBank Chr Locus
Age
ACVR1_E328_R 0.78 0.99 20.403 11.361 7.50E-04 3.88E-02 20.648 55.757 8.20E-14 2.30E-11 ACVR1 NM_001105.2 2 158402708
IL6_E168_F 0.00 0.32 0.476 18.525 1.68E-05 3.86E-03 0.443 37.288 1.02E-09 9.51E-08 IL6 NM_000600.1 7 22733513
CARD15_P302_R 0.17 0.61 20.390 11.309 7.71E-04 3.88E-02 20.440 33.265 8.04E-09 5.63E-07 CARD15 NM_022162.1 16 49288249
PDGFRA_E125_F 0.25 0.98 0.471 17.580 2.75E-05 3.86E-03 0.412 30.935 2.67E-08 1.29E-06 PDGFRA NM_006206.3 4 54790329
NFKB1_P496_F 0.08 0.50 20.422 15.125 1.01E-04 9.39E-03 20.361 30.863 2.77E-08 1.29E-06 NFKB1 NM_003998.2 4 103641022
ELK3_P514_F 0.01 0.28 0.385 11.172 8.30E-04 3.88E-02 0.380 28.501 9.37E-08 3.75E-06 ELK3 NM_005230.2 12 95111824
Gender
TDGF1_P428_R 0.22 0.64 0.791 10.777 1.03E-03 2.88E-02 1.050 41.315 1.30E-10 1.81E-08 TDGF1 NM_003212.1 3 46593789
EVI2A_E420_F 0.27 0.97 0.816 12.815 3.44E-04 1.60E-02 0.796 30.494 3.35E-08 2.34E-06 EVI2A NM_001003927.1 17 26672423
NDN_E131_R 0.54 0.87 1.028 23.063 1.57E-06 4.39E-04 0.487 26.130 3.19E-07 1.79E-05 NDN NM_002487.2 15 21483412
PLAGL1_E68_R 0.63 0.91 0.883 17.177 3.41E-05 4.77E-03 0.628 24.507 7.40E-07 3.46E-05 PLAGL1 NM_002656.2 6 144371178
DNMT2_P199_F 0.75 0.96 0.858 13.209 2.79E-04 1.56E-02 0.686 23.858 1.04E-06 4.15E-05 DNMT2 NM_004412.3 10 17283886
ERN1_P809_R 0.18 0.58 20.868 13.505 2.38E-04 1.56E-02 20.468 22.692 1.90E-06 6.66E-05 ERN1 NM_001433.2 17 59562017
PTHR1_P258_F 0.63 0.86 0.720 9.892 1.66E-03 3.87E-02 0.611 17.822 2.43E-05 6.17E-04 PTHR1 NM_000316.2 3 46893982
XPC_P226_R 0.75 0.99 0.904 14.454 1.44E-04 1.34E-02 0.553 20.202 6.97E-06 1.95E-04 XPC NM_004628.3 3 14195369
PYCARD_P150_F 0.18 0.48 0.756 11.670 6.35E-04 2.22E-02 0.263 10.500 1.19E-03 1.19E-02 PYCARD NM_145182.1 16 31121902
SGCE_P250_R 0.33 0.97 0.803 11.878 5.68E-04 2.22E-02 0.279 9.005 2.69E-03 1.98E-02 SGCE NM_003919.1 7 94123664
doi:10.1371/journal.pone.0006767.t001
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kappa-B subunit 1 (NFKB1) (NM_003998.2), and ETS-domain
protein (ELK) (NM_005229.2). The associations with age of all
251 DNA methylation probes are listed in Supplementary Table
S1.
Gender-related DNA methylation
We next investigated the relationship of DNA methylation
levels with gender. As expected, non-parametric analysis with
Mann-Whitney U test showed that all X-chromosomal probes
on the bead array were significantly more methylated in
females. However, all but two X-linked probes failed the
stringent normality test. For this reason we restricted the
analysis of gender effects to the autosomal loci only. A total of
56 of the autosomal probes (20%) showed a significant effect of
gender in the combined samples (see Supplementary Table S2
for complete list). The DNA methylation status at ten loci was
also significantly associated with gender in the twin and
singleton samples independently (Table 1). Although highly
significant, the mean difference in DNA methylation level even
at the most significant locus (TDGF1_P248_R, NM_003212.1)
in the combined group was modest (0.75, sd 0.04 in females
compared to 0.79, sd 0.04 in males. t=4.5734, df=169.39,
p=9.23e–06). Similar to the age-specific findings, we observed
fairly good overall correlation of the gender effects on DNA
methylation levels in the two sample sets at 0.69 (95% CI:
0.62–0.74).
Heritability
Third, the twin sample was used to obtain heritability estimates
of the observed high-quality DNA methylation profiles. In total, 96
of the 431 CpG sites (23%) yielded a significant heritability
(Table 2). The most significant heritable DNA methylation levels
included sites in AXL receptor tyrosine kinase isoform (AXL)
(NM_001699.3), glutathione S-transferase M1 isoform 2 (GSTM1)
(NM_000561.2), T-cell lymphoma invasion and metastasis 1
(TIAM1) (NM_003253.2) and TEK tyrosine kinase (TEK)
(NM_000459.2) among others (See supplementary table S3 for
full heritability result).
Linkage Disequilibrium mapping
Based on the high heritability estimate of DNA methylation
profiles of multiple CpG sites, we performed association mapping
using DNA methylation levels as quantitative traits. For 91
subjects of the second set, sample genotype data was available
(Illumina 550K BeadChip), with a total of 437,968 SNPs genome-
wide after quality control filtering. Genomic inflation factor as a
measure of population stratification ranged from 0.96 to 1.05, the
mean chi-square statistic ranged between 0.98 and 1.03 indicating
an absence of population stratification. We observed significant
associations between DNA methylation at 11 different CpG loci
representing 35 cis and 5 trans effects after stringent multiple testing
correction and confirmation by permutation testing (Supplemen-
tary Table S4 shows all 106 methylation probes that showed
significant associations after FDR correction for multiple testing,
Table 2. Heritability of probes (top 25 only).
Probe Her Chi2 p-value Symbol GenBank Chr Locus
AXL_P223_R 0.94 54.390 1.64E-13 AXL NM_021913.2 19 46416440
GSTM1_P363_F 0.90 36.833 1.29E-09 GSTM1 NM_146421.1 1 110031602
TIAM1_P188_R 0.76 23.136 1.51E-06 TIAM1 NM_003253.1 21 31853349
CHGA_P243_F 0.87 20.119 7.28E-06 CHGA NM_001275.2 14 92459002
TEK_P479_R 0.72 19.197 1.18E-05 TEK NM_000459.1 9 27098962
HPN_P823_F 0.76 19.065 1.26E-05 HPN NM_182983.1 19 40222427
CREBBP_P712_R 0.73 17.853 2.39E-05 CREBBP NM_004380.1 16 3871424
JAK3_P1075_R 0.67 16.326 5.33E-05 JAK3 NM_000215.2 19 17820875
NPR2_P618_F 0.64 16.126 5.93E-05 NPR2 NM_003995.3 9 35781788
CCL3_E53_R 0.77 15.769 7.16E-05 CCL3 NM_002983.1 17 31441547
NPR2_P1093_F 0.57 15.696 7.44E-05 NPR2 NM_003995.3 9 35781313
HRASLS_P353_R 0.66 15.472 8.37E-05 HRASLS NM_020386.2 3 194441259
MET_E333_F 0.64 15.122 1.01E-04 MET NM_000245.2 7 116100028
HOXA5_P1324_F 0.68 15.054 1.04E-04 HOXA5 NM_019102.2 7 27151136
TSP50_P137_F 0.73 14.607 1.32E-04 TSP50 NM_013270.2 3 46734505
FZD9_E458_F 0.66 14.545 1.37E-04 FZD9 NM_003508.2 7 72486503
CRK_P721_F 0.60 14.229 1.62E-04 CRK NM_005206.3 17 1307015
HHIP_P578_R 0.63 13.141 2.89E-04 HHIP NM_022475.1 4 145786045
IL16_P226_F 0.59 12.836 3.40E-04 IL16 NM_004513.3 15 79262029
ACVR1_E328_R 0.64 12.729 3.60E-04 ACVR1 NM_001105.2 2 158402708
DNAJC15_E26_R 0.67 12.536 3.99E-04 DNAJC15 NM_013238.2 13 42495388
ABCC2_E16_R 0.58 12.367 4.37E-04 ABCC2 NM_000392.1 10 101532577
AXIN1_P995_R 0.61 12.179 4.83E-04 AXIN1 NM_003502.2 16 343460
DDR1_P332_R 0.67 12.085 5.08E-04 DDR1 NM_001954.3 6 30959508
LIG3_P622_R 0.57 11.919 5.56E-04 LIG3 NM_013975.2 17 30331029
doi:10.1371/journal.pone.0006767.t002
DNA Methylation, Age, Gender
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6767uncorrected for the 512 phenotypes tested). It is noticeable that all
significant trans effects are observed with common variants located
within genes, and not positioned in regions with known micro
RNA’s (http://microrna.sanger.ac.uk/). We here present genetic
associations of three DNA methylation loci with nine SNPs that
constituted a mean difference in DNA methylation level larger or
equal than 0.17 to rule out the possibility of technical artifact and
survived corrections for multiple testing both for the number of
SNPs as well as the 512 phenotypes employed (Table 3). An
example plot of DNA methylation differences of ALOX12
(NM_000697.1), the gene locus with the most significant
association of DNA methylation with genotype, is shown in
Figure 1. The heritability of these CpG loci as estimated in the
twin data by means of non-parametric analysis (polychoric
correlations) was significant for ALOX12_E85_R (heritability:
0.48, 95% CI: 0.24–0.61) and KRAS_E82_F (heritability: 0.9
95% CI: 0.79–1), but non-significant for ALOX12_P223_R
(heritability: 0.03, 95% CI: 0–0.3) or MET_E333_F (heritability:
0.07 95% CI:0–0.42). Associations of DNA methylation level of
two X- chromosomal CpG loci (GRPR (Xp22.2, NM_005314.2),
and PCTK1 (Xp11.3, NM_033018.2)) with the SNPs rs12743401,
rs3881953, rs12734338 rendered non-significant after including
gender as a covariate. The association signals are most likely from
a homolog area on the Y chromosome as the association of these
SNPs with male gender (p,1E-8) confirms.
Sequencing
To investigate whether sequence variation at the probe target
regions may affect hybridization and cause spurious association
findings, we performed a targeted sequencing effort of 15 gene
regions. All subjects of the second set were included for sequencing
EVI2A (NM_001003927.1), which showed high heritability and
strong associations with DNA methylation. We used a subset of
subjects representing the upper and lower quartile of DNA
methylation values and homozygosity of the associated alleles for
Figure 1. Sample plot of DNA methylation levels at probe
ALOX12_P223_R by genotype of SNP rs434473.
doi:10.1371/journal.pone.0006767.g001
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CTSD_P726_F, TMPRSS4_P552_F). We observed one novel
sequence variation within the EVI2A_E420_F probe region in one
subject. The remaining six loci did not show any genetic variation.
(Detailed results of sequence data are available upon request.)
Discussion
This study surveys inter-individual DNA methylation in relation
to genotype, age and gender effects simultaneously. Using genomic
DNA extracted from peripheral blood, we analyzed DNA
methylation patterns of a large number of CpG sites from more
than 800 genes spread throughout the genome in 23 monozygotic
and 23 dyzygotic healthy twin-pairs and 96 healthy singletons. We
demonstrate that the application of readily available array based
technology can provide meaningful results that open the
opportunity of incorporating epigenetic information in genetic
studies.
Despite the fact that in the majority (86 percent) of CpG sites
interrogated by this panel, no substantial DNA methylation
variation was present due to tissue type and CpG selection, we did
observe replicable, independent, significant effects of age and
gender on DNA methylation status for some of the remaining sites.
Furthermore, for a number of DNA methylation loci in the twin
data, we observed high heritability values for their DNA
methylation levels. Genome-wide mapping using DNA methyla-
tion as a quantitative trait in 91 healthy singletons with available
SNP data yielded highly significant associations. Particularly some
of the cis effects constituted large effect sizes that are likely to be
biologically relevant and survived strict correction for multiple
testing. Other associations, although statistically significant,
constituted smaller effect sizes and included trans effects of genetic
variation on DNA methylation levels as well. Additional sequence
analysis did not identify DNA variation within the targeted CpG
probe regions that could have lead to spurious association findings
[28]. Our results in the twin data as well as in the singletons
demonstrate the role of genetic variation regulating epigenetic
signals.
The strongest effects of genetic regulation act locally (cis), within
regions that are in linkage disequilibrium with the CpG sites
assayed on the array. However, we also observed a number of
significant genetic associations with DNA methylation status
elsewhere in the genome on other chromosomes (i.e. trans effects)
albeit with small effect sizes and with unknown biological
relevance. Given the fact that trans effects were already observed
in a relatively small sample size of 91 subjects with limited power
in a small subset of CpG methylation sites, it is likely that larger
studies will identify more trans effects and uncover new genetic
regulation of epigenetic profiles. Further non-parametric analysis
of association signals may implicate additional genetic control of
methylation levels. It is noticeable that all significant trans effects
are observed with common variants located within genes instead of
gene deserts, suggesting biologically relevant interactions. How-
ever caution is warranted as some trans effects were identified as
artifacts. For instance the genetic associations in trans from the X-
chromsomal CpG sites were due to homologs of the associated
SNPs on the Y-chromosome and the SNPs (rs1566753, rs4516942)
listed at chromosome 6 but have homologs at chromosome 12 and
therefore most likely constitute cis effects rather trans effects on
methylation levels of the KRAS locus (NM_033360.2) on
chromosome 12. However, another trans effect such as from
rs3134269 in the Solute Carrier Family 25, member 32 gene
(SLC25A32; NC_000008.10) (involved in folate metabolism) that
is associated with DNA methylation levels at TSC2 (tuberous
sclerosis 2, NM_001077183.1) constitute a difference of 0.24
percent, well above detection sensitivity (Supplementary Table
S5). We are not aware of any studies reporting a direct role of this
gene in DNA methylation, but our results suggest that further
studies into the molecular mechanisms of these trans effects are
warranted.
Recent studies have begun to reveal the complex underlying
control mechanisms of DNA methylation but studies of the effect
of sequence variant on DNA methylation levels have yielded
contrasting results [21,29,30]. Our data provides evidence for cis-
acting DNA sequences that exert local epigenetic control possibly
extending over a cluster of nearby genes and suggest the presence
of trans-acting factors not limited to DNA methyltransferases [31].
The SNPs associated with methylation levels in our study were not
positioned in genomic regions with microRNAs and we therefore
are unable to corroborate recent studies suggesting that micro-
RNAs are associated with DNA methylation levels [32,33].
In addition to genetic control of DNA methylation levels, we
found independent associations of DNA methylation with age and
gender. Gender effects for methylation loci on the X chromosome
are largely due to the X-inactivation dosage compensation
mechanism in females [34]. However, we observed that several
of variable autosomal CpG loci on the array are differentially
methylated in females as well. We are not the first to report gender
specific DNA methylation differences suggesting that autosomal
gender dependent DNA methylation is a recurrent phenomenon.
Although the absolute differences in methylation level between
male and female participants was low, nevertheless they constitute
effect sizes similar to previous findings from other groups (Cohen’s
d=1) [26]. Our study is also in agreement with previous reports
that DNA methylation is age related although this may be
restricted to mitotic cells [35] and specific loci [19]. It is
noteworthy that about half of the probes that showed significant
association to age and gender are non-CpG island probes. The
ratio of CpG island in the samples that showed approximate
normal distribution and sufficient range (173 of 280) was
significant lower than in the original set (1044 of 1505) (Chi-
square test: X
2=5.9, df=1, p=0.015). These results support
recent reports that changes in DNA methylation do not
predominantly occur in promoter regions or CpG islands [36].
The DNA methylation loci with high heritability or with
significant associations with age or gender identified in our study
present some genes that have previously been implicated in
disease. For example, the PTHR1 (parathyroid hormone receptor
1, NM_000316.2) gene that was found differentially methylated in
females is associated with bone mineral density that shows
substantial difference between males and females. Sequence
variation of the IL6 gene (NM_000600.1) is related to metabolic
syndrome in older males. Finally the AXIN1 locus (NM_003502.2)
of which DNA methylation levels in peripheral blood has
previously been associated with caudal duplication anomaly
showed high heritability in our sample (heritability: 0.61,
X
2=12.18, p,0.001). Further studies into the phenotypic
consequences of such methylation differences seem warranted.
We realize that these findings are based on a relatively small
sample size with limited statistical power. In addition, the Illumina
GoldenGate Cancer Panel probes represent only a minute fraction
(less than 0.005 percent) of all CpGs in the human genome. On
estimate there are 32 million CpG dinucleotides constituting
approximately 1 one percent of the genome [37,38]. The selection
of CpG probes predominantly in promoter regions of cancer
related genes may not be representative for the vast number of
DNA methylation sites throughout the genome and are known to
be commonly unmethylated in blood [6,27]. A recent study of the
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regions in the genome (whether in the promoter, intragenic or near
the 39 end) exert different effects on gene transcription [39].
Selection of probes with substantial range and proximal normal
distribution as employed in this study focuses on the strongest and
biologically most relevant signals. Further non-parametric analysis
may tease out additional relevant signals but is beyond the scope of
this paper. Technological array-based advances will enable us to
study a much larger number of targeted CpGs, while high-
throughput, next-generation sequencing studies will provide
genome-wide DNA methylation information. Such new develop-
ments may also overcome the current limitations in detection
sensitivity of the Illumina GoldenGate panel applied in this study.
The arrayscandetectDNAmethylationlevelsas lowas2.5percent,
but are generally more accurate detecting higher levels of
methylation (above 10 percent). Bibikova and colleagues suggested
that a beta value difference of $0.17 is needed in analyzing
GoldenGatemethylationdata [40].Whereasthe sensitivitytodetect
differences greater than this difference is excellent, caution is
warranted for smaller differences. The mean differences between
the genotypes presented in Table 4 are all above this detection
threshold as are the ranges in DNA methylation levels that were
significantly associated with age or gender. However the mean
differences between the male and female groups were smaller than
17 percent and should therefore be interpreted with caution.
A remaining challenge will be the study of tissue-specificity of
epigenetic control. We do not know what the meaning of
differential DNA methylation in blood is for other tissues.
Although several studies suggest an important role of DNA
methylation in the specialization of tissues [41] other studies
suggest that the role of DNA methylation in tissue-specific gene
expression is limited to tissue-specific differentially methylated
regions (T-DMRs) [42,43]. Our data are in agreement with those
of Kaminsky et al who reported that the intraclass correlation
between tissue type was significantly higher compared to intra-
individual differences [21]. Nevertheless, further studies that
include several tissue types preferably from single subjects are
necessary [25]. In absence of information on the exact types of
lymphocytes that were included in our blood samples this remains
a potential source of bias in this study too.
DNA methylation information can potentially be applied to the
study of environmental influences, genetic mapping studies and
the development of biomarkers. Further studies may unveil novel
mechanisms by which the environment exerts influence on the
susceptibility to diseases and may also be important for genetic
linkage and association studies. It is possible that DNA
methylation of disease-associated alleles may affect the relative
risk of carriers to develop the trait, cause phenotypic heterogeneity
or may explain some of the phenotypic differences in monozygous
twins [44]. For this reason, incorporating DNA methylation data
with association and linkage analyses may provide new insights for
correlating genetic markers and disease, and thus increase the
power of linkage and association studies. This pilot provides a first
glimpse of the possibilities and hurdles of large-scale DNA
methylation profiling.
Methods
Ethics statement
Written informed consent from all participants was obtained.
This study was approved by the Medical Ethical Committee of the
UMC Utrecht, The Netherlands.
Subjects
The twin sample included 23 healthy monochorionic or
dichorionic monozygotic twin pairs (46 subjects) and 23 healthy
dizygotic twin pairs (an additional 46 subjects) recruited via
advertisements in local newspapers and media. Inclusion criteria
included good general health and at least three Dutch grandpar-
ents. Zygosity of twin pairs was investigated previously by the
Illumina DNA Test Panel consisting of 360 validated single
nucleotide polymorphisms (SNPs). General Health was established
using a general medical checklist; all subjects were free of
medication. An independent second sample set consisted of 96
healthy controls, matched for age and gender to the original twin
series. For this second sample set, genome-wide SNP data
(Illumina 550K Infinium array) was available. The second sample
was used to validate the age and gender effects observed in the
twin sample and to perform genetic mapping using DNA
methylation as quantitative traits. The mean age and gender
information for both sample sets are listed in Table 4.
Laboratory analysis
Genomic DNA extracted from peripheral blood was used for
this study. Experiments of the twin data and singletons were
performed independently. Genomic DNA samples (0.5 mg) from
both sets were bisulfite converted using the EZ-96 DNA
methylation kit (ZYMO Research, Orange, CA, USA) according
to the manufacturer’s protocol in two batches, first the twins and
secondly the singletons. The twins and co-twins were randomly
distributed across plates. DNA methylation profiles were obtained
using the commercially available Illumina GoldenGate DNA
methylation platform (DNA Methylation Cancer Panel I) as
recommended by the manufacturer . With this assay, the DNA
methylation levels of up to 1,505 CpG sites covering 807 gene
regions are interrogated concurrently. The probe IDs are listed in
Supplemental Table S5 and online by the manufacturer (www.
illumina.com/pages.ilmnID193).
Statistical Analysis
We used Illumina BeadStudio software for normalization and initial
quality control. BeadStudio uses a background normalization that
subtracts a background value derived by averaging the signals of built-
Table 4. Sample description.
Twins Singletons All
Monozygotic Dizygotic
N 46 (23 pairs) 46 (23 pairs) 96 188
Mean Age (SD; range) 39.5 (11.1; 20.8–57.8) 39.6 (10.0; 18.8–53.9) 34.2 (16.0; 19.6–66.2) 36.8 (13.3; 18.8–66.2)
Male (%) 20 (43%) 18 (39%) 48 (50%) 86 (46%)
doi:10.1371/journal.pone.0006767.t004
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probe is presented as a Beta value, the ratio of signal from the
methylated probe relative to the sum of both methylated and
unmethylated probes. Beta values can range from 0 (unmethylated)
to 1 (fully methylated). We tested for approximate normal distribution
by means of a Lilliefors test for normality at the 0.1 level after FDR
correction for multiple testing. Non-normal distributed probes were
excluded from subsequent analysis. To ensure biological relevance of
the methylation differences, we also excluded those probes that had a
range smaller than 0.17 in the methylation levels. For further analysis,
we used Z-scores of DNA methylation levels and age in a variance
component analysis.Analysesof age and gender effectswere conducted
for the twins and singletons, both separately and jointly. The effects of
age and gender on the level of methylation were tested in Mx [45]. The
covariance of the methylation levels in MZ and DZ twin-pairs was
estimated to take into account the statistical dependency of the data.
Two parameters were used to model the variances and covariances in
MZ and DZ twins, representing an additive genetic factor (A), and a
unique environmental factor (E). Variances in both MZ and DZ twins
are explained by additive genetic variation and unique environmental
variation, and are therefore estimated as A+E .T h ec o v a r i a n c ei nM Z
twins is expected to equal A, as MZ twins share their genetic material.
T h ec o v a r i a n c ei nD Zt w i n si se x p e c t e dt oe q u a l0 . 5 * A ,a sD Zt w i n s
share 50% of their genetic material. The heritability was estimated as
the additive genetic variance (A) divided by the total amount of
variance (A+E). Heritability Chi-square statistic and probability were
calculated for all the probes that showed approximate normal
distribution and sufficient range in the twins set. We used Mann-
Whitney non-parametric testing to test for differences in DNA
methylation of X-chromosomal probes between males and females,
chi-square test for testing the proportion of CpG islands before and
after filtering. Heritability and standard error non-normal distributed
methylation levels were estimated based on an ACE model using
Falconer’s formulae [46]. Under the ACE model the correlation
between the DZ twins is expected to be equal or higher than half of the
correlation between the MZ twins.
Normalization steps were conducted in BeadStudio, variance
component analysis was conducted using Mx [42] all other
analyses were done using the R package for statistical computing
[47].
Association analysis
We generated SNP genotype data for 91 samples in the
singletons using the Illumina HumanHapmapv1.1 550K platform
at UCLA. Associations with the 512 DNA methylation levels that
were normally distributed in this sample as quantitative pheno-
types, were calculated using PLINK [48]. Provided the small
sample size, we included only SNPs with minor allele frequency
(MAF) at $0.1 and a genotyping success rate of .90%. Markers
deviating from expected Hardy-Weinberg equilibrium at p,0.001
using an exact test [49] were also excluded. Population
stratification was assessed using genomic inflation factor (based
on median chi-squared) and the mean chi-square statistic. We
applied FDR correction at the 0.05 level [50] for multiple testing
by the number of SNPs and the number of phenotypes tested.
Adaptive permutation testing (n=10
7) was performed for the
associated SNPs to confirm our findings. These analyses were
carried out on the Genetic Cluster Computer (http://www.
geneticcluster.org). Association signals that were obtained from X-
chromosomal loci were re-calculated using gender as covariate in a
linear regression model.
Sequencing
To investigate whether DNA sequence variation at probe regions
affected the hybridization signals, we examined several candidate loci
by standard sequencing. Selection of CpG sites for sequencing was
based on the presence of highly significant association findings. All
subjects from the second set were sequenced for PCR amplicons for the
EVI2A_E420 locus; eight selected subjects were used to screen for
sequence variation in the probe regions of ALOX12_P223_R,
TDG_E129_F, CTSD_P726_F, TMPRSS4_P552_F. The latter
subjects were selected by two criteria: DNA methylation levels in the
upper or lower quintile, and homozygosity for the associated SNPs.
The probes were selected from a range of strength of association signals
based on the availability of suitable primers. Primer sequences are
available upon request.
Supporting Information
Table S1 Full age results
Found at: doi:10.1371/journal.pone.0006767.s001 (0.12 MB
XLS)
Table S2 Full gender results
Found at: doi:10.1371/journal.pone.0006767.s002 (0.13 MB
DOC)
Table S3 Full heritability result
Found at: doi:10.1371/journal.pone.0006767.s003 (0.10 MB
DOC)
Table S4 Full mapping results
Found at: doi:10.1371/journal.pone.0006767.s004 (0.06 MB
XLS)
Table S5 Probe IDs
Found at: doi:10.1371/journal.pone.0006767.s005 (1.09 MB
XLS)
Figure S1 Heatmap of twin sample
Found at: doi:10.1371/journal.pone.0006767.s006 (1.28 MB TIF)
Figure S2 Heatmap of singleton sample
Found at: doi:10.1371/journal.pone.0006767.s007 (1.28 MB TIF)
Acknowledgments
The authors wish to thank the subjects for their participation in this study.
We further thank Dr. Peter W. Laird for his support. Drs. Chiara Sabatti,
Ye (Jimmie) Chun, Eleazar Eskin and Caroline van Baal are thanked for
helpful discussion on the statistical approaches, Juliaan Meijboom for his
help with the analysis and Drs. Ronald Vonk and Astrid van der Schot for
collection of the twin samples. Some of the analyses were carried out on the
Genetic Cluster Computer (http://www.geneticcluster.org) which is
financially supported by the Netherlands Scientific Organization (NWO
480-05-003).
Author Contributions
Conceived and designed the experiments: MPB DJW RSK RAO.
Performed the experiments: ES EJ. Analyzed the data: MPB. Contributed
reagents/materials/analysis tools: MPB EMD RAO. Wrote the paper:
MPB EMD DJW IES RSK RAO.
References
1. Cropley JE, Suter CM, Beckman KB, Martin DI (2006) Germ-line epigenetic
modification of the murine A vy allele by nutritional supplementation. Proc Natl
Acad Sci U S A 103: 17308–17312.
2. Weaver IC, Meaney MJ, Szyf M (2006) Maternal care effects on the
hippocampal transcriptome and anxiety-mediated behaviors in the offspring
that are reversible in adulthood. Proc Natl Acad Sci U S A 103: 3480–3485.
DNA Methylation, Age, Gender
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e67673. Rakyan VK, Chong S, Champ ME, Cuthbert PC, Morgan HD, et al. (2003)
Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele
occurs after maternal and paternal transmission. Proc Natl Acad Sci U S A 100:
2538–2543.
4. Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: a landscape takes shape.
Cell 128: 635–638.
5. Metivier R, Gallais R, Tiffoche C, Le PC, Jurkowska RZ, et al. (2008) Cyclical
DNA methylation of a transcriptionally active promoter. Nature 452: 45–50.
6. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev
16: 6–21.
7. Razin A, Shemer R (1995) DNA methylation in early development. Hum Mol
Genet 4 Spec No: 1751–1755.
8. Shemer R, Birger Y, Dean WL, Reik W, Riggs AD, et al. (1996) Dynamic
methylation adjustment and counting as part of imprinting mechanisms. Proc
Natl Acad Sci U S A 93: 6371–6376.
9. Gopisetty G, Ramachandran K, Singal R (2006) DNA methylation and
apoptosis. Mol Immunol 43: 1729–1740.
10. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, et al. (1994) Methylation
of the estrogen receptor gene CpG island marks loss of estrogen receptor
expression in human breast cancer cells. Cancer Res 54: 2552–2555.
11. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358: 1148–1159.
12. Feng YQ, Desprat R, Fu H, Olivier E, Lin CM, et al. (2006) DNA methylation
supports intrinsic epigenetic memory in mammalian cells. PLoS Genet 2: e65.
13. Oates NA, van Vliet J, Duffy DL, Kroes HY, Martin NG, et al. (2006) Increased
DNA methylation at the AXIN1 gene in a monozygotic twin from a pair
discordant for a caudal duplication anomaly. Am J Hum Genet 79: 155–162.
14. Mill J, Dempster E, Caspi A, Williams B, Moffitt T, et al. (2006) Evidence for
monozygotic twin (MZ) discordance in methylation level at two CpG sites in the
promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med
Genet B Neuropsychiatr Genet 141: 421–425.
15. Zhang AP, Yu J, Liu JX, Zhang HY, Du YY, et al. (2007) The DNA methylation
profile within the 59-regulatory region of DRD2 in discordant sib pairs with
schizophrenia. Schizophr Res 90: 97–103.
16. Murphy BC, O’Reilly RL, Singh SM (2008) DNA methylation and mRNA
expression of SYN III, a candidate gene for schizophrenia. BMC Med Genet 9:
115.
17. Connor CM, Akbarian S (2008) DNA methylation changes in schizophrenia and
bipolar disorder. Epigenetics 3: 55–58.
18. Petronis A, Gottesman II, Kan P, Kennedy JL, Basile VS, et al. (2003)
Monozygotic twins exhibit numerous epigenetic differences: clues to twin
discordance? Schizophr Bull 29: 169–178.
19. Heijmans BT, Kremer D, Tobi EW, Boomsma DI, Slagboom PE (2007)
Heritable rather than age-related environmental and stochastic factors dominate
variation in DNA methylation of the human IGF2/H19 locus. Hum Mol Genet
16: 547–554.
20. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, et al. (2008)
Intra-individual change over time in DNA methylation with familial clustering.
JAMA 299: 2877–2883.
21. Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, et al. (2009) DNA
methylation profiles in monozygotic and dizygotic twins. Nat Genet 41:
240–245.
22. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, et al. (2004) Age
related changes in 5-methylcytosine content in human peripheral leukocytes and
placentas: an HPLC-based study. Ann Hum Genet 68: 196–204.
23. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB (1996) Switch from
monoallelic to biallelic human IGF2 promoter methylation during aging and
carcinogenesis. Proc Natl Acad Sci U S A 93: 11757–11762.
24. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. (2005) Epigenetic
differences arise during the lifetime of monozygotic twins. Proc Natl Acad
Sci U S A 102: 10604–10609.
25. Martin GM (2005) Epigenetic drift in aging identical twins. Proc Natl Acad
Sci U S A 102: 10413–10414.
26. El-Maarri O, Becker T, Junen J, Manzoor SS, az-Lacava A, et al. (2007) Gender
specific differences in levels of DNA methylation at selected loci from human
total blood: a tendency toward higher methylation levels in males. Hum Genet
122: 505–514.
27. Rakyan VK, Hildmann T, Novik KL, Lewin J, Tost J, et al. (2004) DNA
methylation profiling of the human major histocompatibility complex: a pilot
study for the human epigenome project. PLoS Biol 2: e405.
28. Alberts R, Terpstra P, Li Y, Breitling R, Nap JP, et al. (2007) Sequence
polymorphisms cause many false cis eQTLs. PLoS ONE 2: e622.
29. Flanagan JM, Popendikyte V, Pozdniakovaite N, Sobolev M, Assadzadeh A, et
al. (2006) Intra- and interindividual epigenetic variation in human germ cells.
Am J Hum Genet 79: 67–84.
30. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, et al. (2004) An
association between variants in the IGF2 gene and Beckwith-Wiedemann
syndrome: interaction between genotype and epigenotype. Hum Mol Genet 13:
247–255.
31. Birger Y, Shemer R, Perk J, Razin A (1999) The imprinting box of the mouse
Igf2r gene. Nature 397: 84–88.
32. Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, et al. (2008)
MicroRNAs control de novo DNA methylation through regulation of
transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol
15: 259–267.
33. Benetti R, Gonzalo S, Jaco I, Munoz P, Gonzalez S, et al. (2008) A mammalian
microRNA cluster controls DNA methylation and telomere recombination via
Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 15:
998.
34. Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, et al. (2008) X-inactivation in
female human embryonic stem cells is in a nonrandom pattern and prone to
epigenetic alterations. Proc Natl Acad Sci U S A 105: 4709–4714.
35. Chu MW, Siegmund KD, Eckstam CL, Kim JY, Yang AS, et al. (2007) Lack of
increases in methylation at three CpG-rich genomic loci in non-mitotic adult
tissues during aging. BMC Med Genet 8: 50.
36. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, et al. (2009) The
human colon cancer methylome shows similar hypo- and hypermethylation at
conserved tissue-specific CpG island shores. Nat Genet 41: 178–186.
37. Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, et al. (1982)
Amount and distribution of 5-methylcytosine in human DNA from different
types of tissues of cells. Nucleic Acids Res 10: 2709–2721.
38. Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG
dinucleotides in the human genome distinguishes two distinct classes of
promoters. Proc Natl Acad Sci U S A 103: 1412–1417.
39. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP (2009) A human B cell
methylome at 100-base pair resolution. Proc Natl Acad Sci U S A 106: 671–678.
40. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High-
throughput DNA methylation profiling using universal bead arrays. Genome
Res 16: 383–393.
41. Nagase H, Ghosh S (2008) Epigenetics: differential DNA methylation in
mammalian somatic tissues. FEBS J 275: 1617–1623.
42. Song F, Smith JF, Kimura MT, Morrow AD, Matsuyama T, et al. (2005)
Association of tissue-specific differentially methylated regions (TDMs) with
differential gene expression. Proc Natl Acad Sci U S A 102: 3336–3341.
43. Kitamura E, Igarashi J, Morohashi A, Hida N, Oinuma T, et al. (2007) Analysis
of tissue-specific differentially methylated regions (TDMs) in humans. Genomics
89: 326–337.
44. Haque FN, Gottesman II, Wong AH (2009) Not really identical: epigenetic
differences in monozygotic twins and implications for twin studies in psychiatry.
Am J Med Genet C Semin Med Genet 151C: 136–141.
45. Neale M, Boker SM, Xie G, Maes HH (2003) Mx: Statistical Modeling.
Richmond, VA: Department of Psychiatry.
46. Falconer DS, Mackay TFC (1996) Introduction to Quantitative Genetics.
Harlow, Essex, UK: Longmans Green.
47. R Development Core Team (2005) R: A Language and Environment for
Statistical Computing, R Foundation for Statistical Computing.
48. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007)
PLINK: A Tool Set for Whole Genome Association and Population Based
Linkage Analyses. Am J Hum Genet 81: 559–75.
49. Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy-
Weinberg equilibrium. Am J Hum Genet 76: 887–893.
50. Benjamini Y, Yekutieli D (2005) Quantitative trait Loci analysis using the false
discovery rate. Genetics 171: 783–790.
DNA Methylation, Age, Gender
PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6767